Autologous stem-cell transplant plus rituximab for newly diagnosed mantle cell lymphoma: Up-date of a phase II trial

被引：0
|
作者：
Hicks, L
Mangel, J
Connors, J
Buckstein, R
Leitch, H
Imrie, K
Crump, M
Spaner, D
Pennell, N
Nagy, T
Boudreau, A
Berinstein, N
机构：
[1] Sunnybrook & Womens Coll Hosp, Toronto, ON, Canada
[2] London Hlth Sci Ctr, London, ON, Canada
[3] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[4] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
454
引用
收藏
页码：170 / 170
页数：1
相关论文
共 50 条
  • [21] High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network
    Hermine, Olivier
    Jiang, Linmiao
    Walewski, Jan
    Bosly, Andre
    Thieblemont, Catherine
    Szymczyk, Michal
    Pott, Christiane
    Salles, Gilles
    Feugier, Pierre
    Hubel, Kai
    Haioun, Corinne
    Casasnovas, Rene Olivier
    Schmidt, Christian
    Bouabdallah, Kamal
    Ribrag, Vincent
    Kanz, Lothar
    Durig, Jan
    Metzner, Bernd
    Sibon, David
    Cheminant, Morgane
    Burroni, Barbara
    Klapper, Wolfram
    Hiddemann, Wolfgang
    Unterhalt, Michael
    Hoster, Eva
    Dreyling, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (03) : 479 - +
  • [22] Rituximab Combined with Chemotherapy and Acalabrutinib Prior to Autologous Stem Cell Transplantation in Mantle Cell Lymphoma: The Rectangle Trial
    Villa, Diego
    Larouche, Jean-Francois
    Cheung, Matthew C.
    Keating, Mary-Margaret
    Zukotynski, Katherine
    Tonseth, Petter
    Mayo, Samantha
    Laister, Robert
    Scott, David W.
    Kuruvilla, John
    BLOOD, 2023, 142
  • [23] Phase II Trial of Bortezomib Plus Rituximab As Maintenance Therapy Post ASCT for Patients with Mantle Cell Lymphoma
    Chen, Robert W.
    Palmer, Joycelynne M.
    Popplewell, Leslie
    Alluin, Jessica
    Chomchan, Pritsana
    Nademanee, Auayporn P.
    Siddiqi, Tanya
    Tsai, Nicole
    Zuo, Fay
    Abary, Rosie
    Cai, Ji-lian
    Rosen, Steven T.
    Forman, Stephen J.
    Kwak, Larry W.
    Holmberg, Leona
    BLOOD, 2017, 130
  • [24] A multi center trial of hyperCVAD plus rituxan in patients with newly diagnosed mantle cell lymphoma
    Epner, Elliot M.
    Unger, Joseph
    Miller, Thomas
    Rimza, Lisa
    Spier, Catherine
    Leblanc, Michael
    Fisher, Richard
    BLOOD, 2007, 110 (11) : 121A - 121A
  • [25] Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma
    Graf, S. A.
    Stevenson, P. A.
    Holmberg, L. A.
    Till, B. G.
    Press, O. W.
    Chauncey, T. R.
    Smith, S. D.
    Philip, M.
    Orozco, J. J.
    Shustov, A. R.
    Green, D. J.
    Libby, E. N., III
    Bensinger, W. I.
    Pagel, J. M.
    Maloney, D. G.
    Zhou, Y.
    Cassaday, R. D.
    Gopal, A. K.
    ANNALS OF ONCOLOGY, 2015, 26 (11) : 2323 - 2328
  • [26] Rituximab and DHAP followed by intensive therapy with autologous stem-cell transplantation as first-line therapy for mantle cell lymphoma
    de Guibert, Sophie
    Jaccard, Arnaud
    Bernard, Marc
    Turlure, Pascale
    Bordessoule, Dominique
    Lamy, Thierry
    HAEMATOLOGICA, 2006, 91 (03) : 425 - 426
  • [27] Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation
    Robert W. Chen
    Joycelynne M. Palmer
    Sarah Tomassetti
    Leslie L. Popplewell
    Jessica Alluin
    Pritsana Chomchan
    Auayporn P. Nademanee
    Tanya Siddiqi
    Ni-Chun Tsai
    Lu Chen
    Fay Zuo
    Rosemarie Abary
    Ji-lian Cai
    Alex F. Herrera
    John J. Rossi
    Steven T. Rosen
    Stephen J. Forman
    Larry W. Kwak
    Leona A. Holmberg
    Journal of Hematology & Oncology, 11
  • [28] Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation
    Chen, Robert W.
    Palmer, Joycelynne M.
    Tomassetti, Sarah
    Popplewell, Leslie L.
    Alluin, Jessica
    Chomchan, Pritsana
    Nademanee, Auayporn P.
    Siddiqi, Tanya
    Tsai, Ni-Chun
    Chen, Lu
    Zuo, Fay
    Abary, Rosemarie
    Cai, Ji-Lian
    Herrera, Alex F.
    Rossi, John J.
    Rosen, Steven T.
    Forman, Stephen J.
    Kwak, Larry W.
    Holmberg, Leona A.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [29] Complete clinical and molecular remissions can be achieved following autologous stem cell transplantation in combination with Rituximab immunotherapy for the treatment of newly diagnosed mantle cell lymphoma.
    Mangel, J
    Buckstein, R
    Imrie, K
    Spaner, D
    Crump, M
    Tompkins, K
    Pennell, N
    Reis, M
    Romans, R
    Robinson, JB
    Richardson, P
    Lima, A
    Pavlin, P
    Boudreau, A
    Nagy, T
    Berinstein, NL
    BLOOD, 2001, 98 (11) : 677A - 677A
  • [30] Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma
    Thomas, Alissa A.
    Abrey, Lauren E.
    Terziev, Robert
    Raizer, Jeffrey
    Martinez, Nina L.
    Forsyth, Peter
    Paleologos, Nina
    Matasar, Matthew
    Sauter, Craig S.
    Moskowitz, Craig
    Nimer, Stephen D.
    DeAngelis, Lisa M.
    Kaley, Thomas
    Grimm, Sean
    Louis, David N.
    Cairncross, J. Gregory
    Panageas, Katherine S.
    Briggs, Samuel
    Faivre, Geraldine
    Mohile, Nimish A.
    Mehta, Jayesh
    Jonsson, Philip
    Chakravarty, Debyani
    Gao, Jianjiong
    Schultz, Nikolaus
    Brennan, Cameron W.
    Huse, Jason T.
    Omuro, Antonio
    NEURO-ONCOLOGY, 2017, 19 (10) : 1380 - 1390
12345